← SynDRA
ZOLANTIDINE
SynDRA canonical compound SYN0003430 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Mechanism of action | histamine receptor antagonist |
|---|
Mechanisms of action (all sources)
- histamine receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- RAB9A
- LMNA
- MAPK1
- MAPT
- MPHOSPH8
- MTOR
- PMP22
- SMAD3
- KCNH2
- SMN1
- TDP1
- THPO
- TP53
- TRPV1
- TSHR
- KDM4A
- IDH1
- ALOX15B
- CYP2D6
- ARSA
- ATXN2
- CBX1
- CYP1A2
- CYP2C19
- CYP2C9
- CYP3A4
- HIF1A
- DRD1
- EHMT2
- GALC
- GLP1R
- GMNN
- HDAC6
- USP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACES
- ESRRA
- PRGR
- PNMT
- NTM1A
- NR1I2
- NNMT
- KSYK
- JUN
- HNMT
- GNMT
- GLI3
- GAMT
- ESR2
- ACM1
- ESR1
- DRD3
- DRD2
- CP3A7
- CP3A4
- CP2D6
- CP1A2
- COMT
- CAC1H
- ANDR
- AHR
- SYK
Drug classes
Cross-references
Synonyms
- SK&F-95282
- SKF-95282
- SK&F 95282
- 2-Benzothiazolamine, N-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)-
- M1108XAY01
- N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]-1,3-benzothiazol-2-amine
- SKF95282;SKF-95282;SKF 95282
- N-(3-(3-(Piperidin-1-ylmethyl)phenoxy)propyl)benzo[d]thiazol-2-amine
- UNII-M1108XAY01
- 2-(3-(3-(Piperidinomethyl)phenoxy)propylamino)benzothiazole
- Tocris-1070
- Lopac-S-5317
- Lopac0_001245
- CHEMBL419296
- DTXSID6048460
- SCHEMBL10400337
- CHEBI:92158
- ZINC2386778
- 2-Benzothiazolamine,N-[3-[3-(1-piperidinylmethyl)phenoxy]propyl]-
- CCG-205319
- SDCCGSBI-0051212.P002
- NCGC00015957-01
- NCGC00015957-02
- NCGC00015957-03
- NCGC00015957-04
- NCGC00015957-05
- NCGC00024980-01
- NCGC00024980-02
- NCGC00024980-03
- L000637
- Q8073549
- BRD-K08996725-313-01-7
- 2-[3-[3-(Piperidinomethyl)phenoxy]propylamino]benzthiazole
- RefChem:926749
- DTXCID2028434
- KUBONGDXTUOOLM-UHFFFAOYSA-N
- EX-A15368
Look up ZOLANTIDINE in the interactive SynDRA portal →